Home
/
Treatment
/
N-tert-butyl-3-[(5-methyl-2-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}pyrimidin-4-yl)amino] benzenesulfonamide dihydrochloride monohydrate

N-tert-butyl-3-[(5-methyl-2-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}pyrimidin-4-yl)amino] benzenesulfonamide dihydrochloride monohydrate

	N-tert-butyl-3-[(5-methyl-2-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}pyrimidin-4-yl)amino] benzenesulfonamide dihydrochloride monohydrate
Trade Name
Orphan Indication	Polycythemia vera
USA Market Approval	USA
USA Designation Date	2013-03-21 00:00:00
Sponsor	Impact Biomedicines;12526 High Bluff Drive, Suite 260;San Diego, California, 92130

Related Access Program

Washington University School of Medicine – Polycythemia vera Novartis Pharmaceuticals – Polycythemia vera